Recognition List Number: 020 Publication Date: 09/09/2008
Part B: SUPPLEMENTARY INFORMATION
Recognition Number 7-159: CLSI H21-A5, Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays. (InVitro Diagnostics)
Date of Standard: 2008. |
| Address of Standards Organization: |
| Clinical Laboratory Standards Institute (CLSI) |
| 950 West Valley Road |
| Suite 2500 |
| Wayne, PA 19087 |
| |
|
| CDRH Offices and Divisions Associated with Recognized Standards: |
| (1) | OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR) | | DIVISION OF CHEMISTRY AND TOXICOLOGY DEVICES (DCTD) |
|
| (2) | OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR) | | DIVISION OF IMMUNOLOGY AND HEMATOLOGY DEVICES (DIHD) |
|
| (3) | OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR) | | DIVISION OF MICROBIOLOGY (DMD) |
|
|
| Devices Affected: |
| Hematology devices using blood specimens for coagulation testing. |
|
| Processes Affected: |
| 510(k), PMA, PDP, IDE, HDE |
|
| Type of Standard: |
| Vertical, National |
| Extent of Recognition: |
|
| Related CFR Citations and Product Codes: |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.5400 |
Fibrometer |
Class 2 |
GIE |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.5425 |
Control, Plasma, Abnormal |
Class 2 |
GGC |
| §864.5425 |
Plasma, Coagulation Control |
Class 2 |
GGN |
| §864.5425 |
Plasma, Control, Normal |
Class 2 |
GIZ |
| §864.5425 |
System, Multipurpose For In Vitro Coagulation Studies |
Class 2 |
JPA |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.5680 |
Analyzer, Heparin, Automated |
Class 2 |
JOX |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7060 |
Antigen, Antiserum, Control, Antithrombin Iii |
Class 2 |
DDQ |
| §864.7060 |
Antithrombin Iii Quantitation |
Class 2 |
JBQ |
| §864.7060 |
Antithrombin Iii, Two Stage Clotting Time Assay |
Class 2 |
JPE |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7290 |
Plasma, Coagulation Factor Deficient |
Class 2 |
GJT |
| §864.7290 |
Test, Qualitative And Quantitative Factor Deficiency |
Class 2 |
GGP |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7320 |
Fibrin Split Products |
Class 2 |
GHH |
| §864.7320 |
Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control |
Class 2 |
DAP |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7525 |
Assay, Heparin |
Class 2 |
KFF |
| §864.7525 |
Protamine Sulphate |
Class 2 |
GFT |
| §864.7525 |
Test, Heparin Neutralization |
Class 2 |
JBR |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7750 |
Test, Time, Prothrombin |
Class 2 |
GJS |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7875 |
Test, Thrombin Time |
Class 2 |
GJA |
| §864.7875 |
Thrombin |
Class 2 |
GJB |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.7925 |
Activated Partial Thromboplastin |
Class 2 |
GFO |
| §864.7925 |
Reagent & Control, Partial Thromboplastin Time |
Class 2 |
GIT |
| §864.7925 |
Reagent, Thromboplastin And Control |
Class 2 |
GGO |
| §864.7925 |
Test, Time, Partial Thromboplastin |
Class 2 |
GGW |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §864.8950 |
Reagent, Russel Viper Venom |
Class 1 |
GIR |
| |
|
| Relevant Guidance: |
NCCLS:
C28-A2 - How to Define and Determine Reference Intervals in the Clinincal Laboratory; Approved Guideline - Second Edition (2000) H1-A5 - Tubes and Additives for Venous Blood Specimen Collection; Approved Standard - Fifth Edition (2003) H3-A5 - Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; Approved Standard - Fifth Edition (2003) H47-A - One Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT Test); - Approved Guideline (1996) |
|
| FDA Technical Contact: |
| Valerie R. Ginyard |
| FDA/CDRH/OIVD |
| 10903 New Hampshire Avenue Building 66, Room 4258 |
| Silver Spring MD 20993 |
| 301/796-6168 |
| Email: valerie.ginyard@fda.hhs.gov |
|
|
|
|